DEVRIAZ Trademark

Trademark Overview

On Monday, December 21, 2020, a trademark application was filed for DEVRIAZ with the United States Patent and Trademark Office. The USPTO has given the DEVRIAZ trademark a serial number of 90398297. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 21, 2024. This trademark is owned by Pfizer Inc.. The DEVRIAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, smoking cessation preparations; vaccines for human use
devriaz

General Information

Serial Number90398297
Word MarkDEVRIAZ
Filing DateMonday, December 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, December 24, 2020NEW APPLICATION ENTERED
Friday, March 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 11, 2021ASSIGNED TO EXAMINER
Saturday, June 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 10, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Monday, February 14, 2022SOU EXTENSION 1 FILED
Monday, February 14, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 3, 2022SOU EXTENSION 2 FILED
Wednesday, August 3, 2022SOU EXTENSION 2 GRANTED
Friday, August 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 3 FILED
Friday, March 3, 2023SOU EXTENSION 3 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023SOU EXTENSION 4 FILED
Thursday, August 17, 2023SOU EXTENSION 4 GRANTED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 27, 2024SOU EXTENSION 5 FILED
Tuesday, February 27, 2024SOU EXTENSION 5 GRANTED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 21, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

devriaz preparations pharmaceutical disorders treatment cancer hypertension pain arthritis blood stroke